Volume 62, Issue 2, Pages (August 2012)

Slides:

Advertisements

Similar presentations

Volume 61, Issue 5, Pages (May 2012)

Advertisements

Volume 68, Issue 6, Pages (December 2015)

Volume 62, Issue 3, Pages (September 2012)

Volume 50, Issue 3, Pages (September 2006)

Large-scale independent validation of the nuclear factor-kappa B p65 prognostic biomarker in prostate cancer Philippe O. Gannon, Laurent Lessard, Louis-Mathieu.

The PSA Era is not Over for Prostate Cancer

Volume 55, Issue 6, Pages (June 2009)

Oncological outcomes of high risk prostate cancer patients between robot-assisted laparoscopic radical prostatectomy and laparoscopic radical prostatectomy.

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Volume 69, Issue 4, Pages (April 2016)

Volume 58, Issue 2, Pages (August 2010)

Volume 44, Issue 6, Pages (December 2003)

Volume 58, Issue 4, Pages (October 2010)

Volume 65, Issue 3, Pages (March 2014)

Testosterone Therapy in Men With Prostate Cancer

Volume 58, Issue 5, Pages (November 2010)

Volume 63, Issue 4, Pages (April 2013)

The Effect of Other-cause Mortality Adjustment on Access to Alternative Treatment Modalities for Localized Prostate Cancer Among African American Patients

Prostate Cancer: Highlights from 2006

Volume 51, Issue 6, Pages (June 2007)

Volume 74, Issue 2, Pages (August 2018)

Volume 46, Issue 3, Pages (September 2004)

Open Retropubic Nerve-Sparing Radical Prostatectomy

Volume 71, Issue 3, Pages (March 2017)

Volume 52, Issue 1, Pages (July 2007)

Volume 51, Issue 4, Pages (April 2007)

Nerve Distribution along the Prostatic Capsule

Let the Games Begin (with EAU Approval)

Volume 73, Issue 5, Pages (May 2018)

Volume 52, Issue 4, Pages (October 2007)

Volume 58, Issue 1, Pages (July 2010)

Volume 59, Issue 2, Pages (February 2011)

The Aging Prostate Is Never “Normal”: Implications from the Genomic Characterization of Multifocal Prostate Cancers Thorsten Schlomm, Joachim Weischenfeldt,

Volume 69, Issue 4, Pages (April 2016)

The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.

Pitfalls of Pathologic Staging in Prostate Cancer

Volume 53, Issue 4, Pages (April 2008)

Prostate Cancer Detection: A View of the Future

Volume 62, Issue 2, Pages (August 2012)

Volume 65, Issue 3, Pages (March 2014)

Volume 68, Issue 3, Pages (September 2015)

Volume 67, Issue 3, Pages (March 2015)

Volume 56, Issue 2, Pages (August 2009)

Low-risk Prostate Cancer: Identification, Management, and Outcomes

The PSA Era is not Over for Prostate Cancer

Volume 63, Issue 3, Pages (March 2013)

Volume 61, Issue 5, Pages (May 2012)

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Volume 63, Issue 3, Pages (March 2013)

Rectal Injury During Radical Prostatectomy: Focus on Robotic Surgery

Volume 74, Issue 3, Pages (September 2018)

Selma Masic, Janet E. Cowan, Samuel L. Washington, Hao G

Volume 3, Issue 2, Pages (June 2005)

Prostate Cancer Nomograms: An Update

Volume 49, Issue 6, Pages (June 2006)

Volume 53, Issue 1, Pages (January 2008)

Volume 74, Issue 4, Pages (October 2018)

Trend of Adverse Stage Migration in Patients Treated with Radical Prostatectomy for Localized Prostate Cancer Felix Preisser, Michele Marchioni, Sebastiano.

Jonathan S. Brajtbord, Michael S. Leapman, Matthew R. Cooperberg

Luis Martínez-Piñeiro European Urology

Volume 55, Issue 6, Pages (June 2009)

Volume 54, Issue 2, Pages (August 2008)

Volume 54, Issue 1, Pages (July 2008)

Volume 52, Issue 4, Pages (October 2007)

Edith Canby-Hagino, Javier Hernandez, Timothy C. Brand, Ian Thompson

Volume 53, Issue 2, Pages (February 2008)

Fernando P. Secin, Fernando J. Bianco, Nicholas T

European Urology Oncology

Volume 54, Issue 1, Pages (July 2008)

Volume 51, Issue 5, Pages (May 2007)

Presentation transcript:

Volume 62, Issue 2, Pages 333-340 (August 2012) Neurovascular Structure-adjacent Frozen-section Examination (NeuroSAFE) Increases Nerve-sparing Frequency and Reduces Positive Surgical Margins in Open and Robot- assisted Laparoscopic Radical Prostatectomy: Experience After 11 069 Consecutive Patients Thorsten Schlomm, Pierre Tennstedt, Caroline Huxhold, Thomas Steuber, Georg Salomon, Uwe Michl, Hans Heinzer, Jens Hansen, Lars Budäus, Stefan Steurer, Corinna Wittmer, Sarah Minner, Alexander Haese, Guido Sauter, Markus Graefen, Hartwig Huland European Urology Volume 62, Issue 2, Pages 333-340 (August 2012) DOI: 10.1016/j.eururo.2012.04.057 Copyright © 2012 European Association of Urology Terms and Conditions

Fig. 1 Neurovascular structure-adjacent frozen-section examination specimen of the left prostatic side, including the whole rectolateral aspect of the prostate. European Urology 2012 62, 333-340DOI: (10.1016/j.eururo.2012.04.057) Copyright © 2012 European Association of Urology Terms and Conditions

Fig. 2 Oncologic outcome of neurovascular structure-adjacent frozen-section examination (NeuroSAFE) and non-NeuroSAFE patients. Inset table presents 5-yr biochemical recurrence (BCR)–free survival probability and p values of the log-rank test. PSA=prostate-specific antigen. European Urology 2012 62, 333-340DOI: (10.1016/j.eururo.2012.04.057) Copyright © 2012 European Association of Urology Terms and Conditions

Fig. 3 Oncologic outcome of patients converted from positive surgical margin (PSM) to negative SM (NSM) by secondary wide resection (converted SM) and patients with primarily NSM. Inset table presents 5-yr biochemical resistance (BCR)–free survival probability and p values of the log-rank test. Due to low numbers, data for pT3a and pT3b tumors were combined. PSA=prostate-specific antigen. European Urology 2012 62, 333-340DOI: (10.1016/j.eururo.2012.04.057) Copyright © 2012 European Association of Urology Terms and Conditions